• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用自然杀伤细胞作为白血病的免疫疗法。

Use of natural killer cells as immunotherapy for leukaemia.

作者信息

Grzywacz Bartosz, Miller Jeffrey S, Verneris Michael R

机构信息

Division of Blood and Marrow Transplantation, University of Minnesota, MN, USA.

出版信息

Best Pract Res Clin Haematol. 2008 Sep;21(3):467-83. doi: 10.1016/j.beha.2008.07.008.

DOI:10.1016/j.beha.2008.07.008
PMID:18790450
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2615405/
Abstract

Natural killer (NK) cells potentially play a significant role in eradicating residual disease following allogeneic haematopoietic cell transplantation, and have been explored as tools for adoptive immunotherapy for chemotherapy-refractory patients. NK cell cytotoxicity is modulated by multiple activating and inhibitory receptors that maintain a balance between self-tolerance and providing surveillance against pathogens and malignant transformation. The functional characteristics of NK cells are dictated by the strength of inhibitory receptor signalling. Major histocompatibility complex (MHC)-specific inhibitory receptor acquisition occurs sequentially during NK cell development, and is determined by the nature of immunological reconstitution after allogeneic haematopoietic cell transplantation. Polymorphisms of inhibitory receptors [killer immunoglobulin-like receptors (KIRs)] and their ligands (MHC) contribute to interindividual variability. As a result, the functional NK cell repertoire of individual donors has variable potential for graft-vs-leukaemia reactions. Models predicting NK cell alloreactivity, including KIR ligand mismatch and missing KIR ligand strategies, are discussed as algorithms for optimal NK cell donor selection. Future modifications to improve NK cell adoptive immunotherapy by means of increasing target recognition and reducing inhibitory signalling are being explored.

摘要

自然杀伤(NK)细胞在异基因造血细胞移植后清除残留疾病方面可能发挥重要作用,并且已被探索作为化疗难治性患者过继性免疫治疗的工具。NK细胞的细胞毒性由多种激活和抑制性受体调节,这些受体在自身耐受与对病原体和恶性转化的监测之间保持平衡。NK细胞的功能特性由抑制性受体信号传导的强度决定。主要组织相容性复合体(MHC)特异性抑制性受体的获得在NK细胞发育过程中依次发生,并由异基因造血细胞移植后的免疫重建性质决定。抑制性受体[杀伤细胞免疫球蛋白样受体(KIR)]及其配体(MHC)的多态性导致个体间的差异。因此,个体供体的功能性NK细胞库对移植物抗白血病反应具有不同的潜力。预测NK细胞同种异体反应性的模型,包括KIR配体错配和缺失KIR配体策略,作为最佳NK细胞供体选择的算法进行了讨论。目前正在探索通过增强靶标识别和减少抑制性信号传导来改进NK细胞过继性免疫治疗的未来改进方法。

相似文献

1
Use of natural killer cells as immunotherapy for leukaemia.使用自然杀伤细胞作为白血病的免疫疗法。
Best Pract Res Clin Haematol. 2008 Sep;21(3):467-83. doi: 10.1016/j.beha.2008.07.008.
2
Natural killer cells as a therapeutic tool in mismatched transplantation.自然杀伤细胞作为不匹配移植中的一种治疗工具。
Best Pract Res Clin Haematol. 2004 Sep;17(3):427-38. doi: 10.1016/j.beha.2004.05.010.
3
Natural killer cells in the treatment of high-risk acute leukaemia.自然杀伤细胞在高危急性白血病治疗中的应用。
Semin Immunol. 2014 Apr;26(2):173-9. doi: 10.1016/j.smim.2014.02.004. Epub 2014 Mar 5.
4
Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation.HLA匹配的造血细胞移植后NK细胞受体库的重建。
Blood. 2003 May 1;101(9):3730-40. doi: 10.1182/blood-2002-08-2568. Epub 2003 Jan 2.
5
Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation.打破对自身的耐受性,在去除T细胞的异基因造血细胞移植后,表达针对非自身HLA的抑制性杀伤细胞免疫球蛋白样受体的循环自然杀伤细胞表现出效应功能。
Blood. 2009 Apr 16;113(16):3875-84. doi: 10.1182/blood-2008-09-177055. Epub 2009 Jan 28.
6
Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells.具有杀伤性免疫球蛋白样受体配体不相容性的同种异体自然杀伤细胞对黑色素瘤和肾细胞癌细胞的细胞毒性增强。
Blood. 2004 Jul 1;104(1):170-7. doi: 10.1182/blood-2003-12-4438. Epub 2004 Mar 11.
7
Clinical applications of adoptive natural killer cell immunotherapy for cancer: current status and future prospects.过继性自然杀伤细胞免疫疗法在癌症治疗中的临床应用:现状与未来展望
Onkologie. 2010;33(7):389-95. doi: 10.1159/000315698. Epub 2010 Jun 21.
8
Use of NK cell activity in cure by transplant.使用 NK 细胞活性进行移植治疗。
Br J Haematol. 2011 Oct;155(1):14-29. doi: 10.1111/j.1365-2141.2011.08823.x. Epub 2011 Aug 4.
9
Opportunities and limitations of natural killer cells as adoptive therapy for malignant disease.自然杀伤细胞作为恶性疾病过继性治疗手段的机遇与局限
Cytotherapy. 2014 Nov;16(11):1453-1466. doi: 10.1016/j.jcyt.2014.03.009. Epub 2014 May 20.
10
Exploitation of natural killer cells for the treatment of acute leukemia.利用自然杀伤细胞治疗急性白血病。
Blood. 2016 Jun 30;127(26):3341-9. doi: 10.1182/blood-2015-12-629055. Epub 2016 May 20.

引用本文的文献

1
Natural Killer Cell Homing and Persistence in the Bone Marrow After Adoptive Immunotherapy Correlates With Better Leukemia Control.过继免疫治疗后,自然杀伤细胞在骨髓中的归巢和持久性与更好的白血病控制相关。
J Immunother. 2019 Feb/Mar;42(2):65-72. doi: 10.1097/CJI.0000000000000250.
2
Fewer Circulating Natural Killer Cells 28 Days After Double Cord Blood Transplantation Predicts Inferior Survival and IL-15 Response.双份脐血移植后28天循环自然杀伤细胞数量减少预示生存率较低及白细胞介素-15反应不佳。
Blood Adv. 2016 Dec 27;1(3):208-218. doi: 10.1182/bloodadvances.2016000158. Epub 2016 Oct 30.
3
CD56bright NK cells exhibit potent antitumor responses following IL-15 priming.

本文引用的文献

1
Pillars article: Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999. 286: 1957-1959.专栏文章:家族性噬血细胞性淋巴组织细胞增生症中的穿孔素基因缺陷。《科学》。1999年。第286卷:第1957 - 1959页。
J Immunol. 2015 Jun 1;194(11):5044-6.
2
Sensitization of tumor cells to NK cell-mediated killing by proteasome inhibition.通过蛋白酶体抑制使肿瘤细胞对自然杀伤细胞介导的杀伤作用敏感化。
J Immunol. 2008 Jan 1;180(1):163-70. doi: 10.4049/jimmunol.180.1.163.
3
The type of ATG matters -- natural killer cells are influenced differentially by Thymoglobulin, Lymphoglobulin and ATG-Fresenius.
CD56bright自然杀伤细胞在白细胞介素-15启动后表现出强大的抗肿瘤反应。
J Clin Invest. 2017 Nov 1;127(11):4042-4058. doi: 10.1172/JCI90387. Epub 2017 Oct 3.
4
Partial break in tolerance of NKG2A/LIR-1 single KIR NK cells early in the course of HLA-matched, KIR-mismatched hematopoietic cell transplantation.在 HLA 匹配、KIR 错配的造血细胞移植过程中,NKG2A/LIR-1 单 KIR NK 细胞的部分耐受中断。
Bone Marrow Transplant. 2017 Aug;52(8):1144-1155. doi: 10.1038/bmt.2017.81. Epub 2017 May 8.
5
Opportunities and limitations of natural killer cells as adoptive therapy for malignant disease.自然杀伤细胞作为恶性疾病过继性治疗手段的机遇与局限
Cytotherapy. 2014 Nov;16(11):1453-1466. doi: 10.1016/j.jcyt.2014.03.009. Epub 2014 May 20.
6
Allele-level haplotype frequencies and pairwise linkage disequilibrium for 14 KIR loci in 506 European-American individuals.14 个 KIR 基因座在 506 名欧洲裔个体中的等位基因水平单体型频率和双等位基因连锁不平衡。
PLoS One. 2012;7(11):e47491. doi: 10.1371/journal.pone.0047491. Epub 2012 Nov 5.
7
NOD2 Polymorphisms and Their Impact on Haematopoietic Stem Cell Transplant Outcome.NOD2基因多态性及其对造血干细胞移植结果的影响。
Bone Marrow Res. 2012;2012:180391. doi: 10.1155/2012/180391. Epub 2012 Oct 18.
8
A perspective on the selection of unrelated donors and cord blood units for transplantation.移植中无关供者和脐带血单位选择的观点。
Blood. 2012 Jul 12;120(2):259-65. doi: 10.1182/blood-2012-03-379032. Epub 2012 May 17.
9
Umbilical cord blood immunology: relevance to stem cell transplantation.脐带血免疫学:与干细胞移植的相关性。
Clin Rev Allergy Immunol. 2012 Feb;42(1):45-57. doi: 10.1007/s12016-011-8289-4.
10
Cellular therapies in acute lymphoblastic leukemia.急性淋巴细胞白血病的细胞治疗。
Hematol Oncol Clin North Am. 2011 Dec;25(6):1281-301. doi: 10.1016/j.hoc.2011.09.015.
抗胸腺细胞球蛋白的类型很重要——自然杀伤细胞受兔抗人胸腺细胞球蛋白、淋巴细胞球蛋白和费森尤斯抗胸腺细胞球蛋白的影响不同。
Transpl Immunol. 2007 Nov;18(2):85-7. doi: 10.1016/j.trim.2007.05.001. Epub 2007 Jun 12.
4
Inhibitory KIR-HLA receptor-ligand mismatch in autologous haematopoietic stem cell transplantation for solid tumour and lymphoma.实体瘤和淋巴瘤自体造血干细胞移植中抑制性杀伤细胞免疫球蛋白样受体-人类白细胞抗原受体-配体错配
Br J Cancer. 2007 Aug 20;97(4):539-42. doi: 10.1038/sj.bjc.6603913. Epub 2007 Jul 31.
5
KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro.KIR2DS1阳性自然杀伤细胞在体外介导针对C2 HLA-KIR配体组的同种异体反应。
J Immunol. 2007 Jul 15;179(2):854-68. doi: 10.4049/jimmunol.179.2.854.
6
CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts.CD56 明亮型人类自然杀伤细胞分化为 CD56 暗淡型细胞:与外周成纤维细胞接触的作用。
J Immunol. 2007 Jul 1;179(1):89-94. doi: 10.4049/jimmunol.179.1.89.
7
An open-label, two-arm, phase I trial of recombinant human interleukin-21 in patients with metastatic melanoma.一项针对转移性黑色素瘤患者的重组人白细胞介素-21的开放标签、双臂、I期试验。
Clin Cancer Res. 2007 Jun 15;13(12):3630-6. doi: 10.1158/1078-0432.CCR-07-0410.
8
Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells.TLR7/8激活的炎性树突状细胞的杀瘤活性。
J Exp Med. 2007 Jun 11;204(6):1441-51. doi: 10.1084/jem.20070021. Epub 2007 May 29.
9
The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations.环孢素A对CD56+CD16-和CD56+CD16+自然杀伤细胞亚群的意外作用。
Blood. 2007 Sep 1;110(5):1530-9. doi: 10.1182/blood-2006-10-048173. Epub 2007 May 10.
10
Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation.A组和B组KIR单倍型与HLA I类配体的供者-受者组合会影响HLA匹配的同胞供者造血细胞移植的结果。
Hum Immunol. 2007 May;68(5):309-23. doi: 10.1016/j.humimm.2007.01.019. Epub 2007 Mar 12.